| 2026-04-28 16:05 |
8-K |
["2.01"] |
tender offer |
1.00
|
Gilead Sciences completed tender offer and merger with Arcellx for $115/share plus CVR, effective April 28, 2026. |
SEC · detail |
| 2026-04-28 09:04 |
SC 14D9 |
|
tender offer |
1.00
|
Gilead Sciences acquisition of Arcellx for $115/share + CVR completed; tender offer expired with 77.2% acceptance. |
SEC · detail |
| 2026-04-28 08:53 |
SC TO-T |
|
tender offer |
1.00
|
Gilead Sciences completed tender offer for Arcellx at $115/share plus CVR; merger closing April 28, 2026. |
SEC · detail |